...
首页> 外文期刊>Annals of vascular surgery >Use of a totally implantable access port through the external jugular vein when the cephalic vein approach is not feasible.
【24h】

Use of a totally implantable access port through the external jugular vein when the cephalic vein approach is not feasible.

机译:当头颈静脉入路不可行时,通过颈外静脉使用完全可植入的进入端口。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: We report our experience of using a totally implantable access port (TIAP) through the external jugular vein (EJV) when the cephalic vein (CV) approach is not feasible. METHODS: We reviewed 197 cases involving TIAP implantation through the EJV in a single medical center between January 1995 and January 2009. All the ports were implanted after the CV approach was found unfeasible. Patient characteristics, operating time, and early and late complications were recorded. RESULTS: The mean patient age was 50 years (range: 33-75). The mean operating time was 54.5 +/- 7.5 minutes. Early complications within the first 30 postoperative days included port hematoma (2%) and catheter migration (2%). The late postoperative complications included catheter occlusion (2.5%), venous thrombosis (2%), and port infection (1.5%). There were no complications associated with TIAP disconnection. CONCLUSIONS: The EJV approach is an easy and safe alternative method for TIAP implantation when the CV approach is not feasible. This method can avoid conversion to percutaneous puncture of the subclavian vein, which could result in life-threatening complications such as pneumothorax and hemothorax. In patients with breast cancer or those who are contraindicated for TIAP implantation on the opposite side, the EJV cutdown approach provides an alternative route with comfortable and satisfactory results as complications with this approach are rare.
机译:背景:我们报告了在头颈静脉(CV)方法不可行时通过颈外静脉(EJV)使用完全植入式进入端口(TIAP)的经验。方法:我们回顾了1995年1月至2009年1月间在单个医疗中心通过EJV植入TIAP的197例病例。在发现CV方法不可行后,所有端口均被植入。记录患者的特征,手术时间以及早期和晚期并发症。结果:患者平均年龄为50岁(范围:33-75)。平均操作时间为54.5 +/- 7.5分钟。术后头30天内的早期并发症包括端口血肿(2%)和导管迁移(2%)。术后晚期并发症包括导管阻塞(2.5%),静脉血栓形成(2%)和端口感染(1.5%)。没有与TIAP断开相关的并发症。结论:当CV方法不可行时,EJV方法是TIAP植入的一种简单,安全的替代方法。这种方法可以避免转化为锁骨下静脉经皮穿刺,否则可能导致危及生命的并发症,如气胸和血胸。对于乳腺癌患者或禁忌在另一侧进行TIAP植入的患者,EJV切除术提供了另一种途径,具有舒适且令人满意的结果,因为这种方法的并发症很少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号